Javascript is disabled or is not supported by your browser. Please upgrade your browser or enable Javascript to navigate the interface properly.

First Light Asset Management

Latest statistics and disclosures from First Light Asset Management's latest quarterly 13F-HR filing:

Top 5 stock holdings are AXGN, PHLT, CNTA, NEO, AMLX, and represent 38.14% of First Light Asset Management's stock portfolio.
Added to shares of these 10 stocks: AMLX (+$46M), PVLA (+$34M), LENZ (+$32M), NEO (+$24M), AXGN (+$23M), MRUS (+$21M), RYTM (+$18M), IRON (+$15M), MASS (+$13M), MDXG (+$12M).
Started 9 new stock positions in LENZ, RYTM, IRON, MRUS, AMLX, PVLA, MDGL, ABVX, TECX.
Reduced shares in these 10 stocks: ANAB (-$78M), CNTA (-$16M), PHLT (-$11M), BFLY (-$8.4M), RARE (-$7.9M), SENS (-$7.7M), ELDN (-$7.0M), INSM (-$6.3M), XENE (-$5.9M), IRTC (-$5.5M).
Sold out of its positions in ELDN, EOLS, INSM, JANX, LNTH, XENE.
First Light Asset Management was a net buyer of stock by $119M.
First Light Asset Management has $1.1B in assets under management (AUM), dropping by 37.53%.
Central Index Key (CIK): 0001600004

Tip: Access up to 7 years of quarterly data

Positions held by First Light Asset Management consolidated in one spreadsheet with up to 7 years of data

Download as csv

Download as Excel

Portfolio Holdings for First Light Asset Management

First Light Asset Management holds 41 positions in its portfolio as reported in the September 2025 quarterly 13F filing

Company (Ticker)	Portfolio Weight	Valued At	Change in Shares	Share Count	Share Price
Axogen Common Stocks (AXGN)	9.8	$104M	+28%	5.8M	17.84	View chart
Performant Healthcare Common Stocks (PHLT)	8.5	$91M	-11%	12M	7.73	View chart
Centessa Pharmaceuticals Common Stocks (CNTA)	8.3	$88M	-15%	3.6M	24.25	View chart
Neogenomics Common Stocks (NEO)	7.2	$77M	+44%	9.9M	7.72	View chart
Amylyx Pharmaceuticals Common Stocks (AMLX)	4.3	$46M	NEW	3.4M	13.59	View chart
Crinetics Pharmaceuticals Common Stocks (CRNX)	3.7	$39M	+8%	942k	41.65	View chart
Health Catalyst Common Stocks (HCAT)	3.6	$38M	+9%	13M	2.85	View chart
Palvella Therapeutics Common Stocks (PVLA)	3.2	$34M	NEW	542k	62.69	View chart
Twist Bioscience Corporation Common Stocks (TWST)	3.2	$34M	+26%	1.2M	28.14	View chart
Lenz Therapeutics Common Stocks (LENZ)	3.0	$32M	NEW	693k	46.58	View chart
Organogenesis Holdings Common Stocks (ORGO)	3.0	$32M	+10%	7.5M	4.22	View chart
Atricure Common Stocks (ATRC)	3.0	$31M	-12%	890k	35.25	View chart
Anaptys Bio Common Stocks (ANAB)	2.9	$30M	-72%	990k	30.62	View chart
Si-bone Common Stocks (SIBN)	2.7	$28M	+9%	1.9M	14.72	View chart
Cidara Therapeutics Common Stocks (CDTX)	2.6	$28M	+62%	293k	95.76	View chart
Irhythm Technologies Common Stocks (IRTC)	2.5	$27M	-17%	155k	171.99	View chart
Mimedx Group Common Stocks (MDXG)	2.4	$26M	+89%	3.7M	6.98	View chart
Edgewise Therapeutics Common Stocks (EWTX)	2.2	$23M	-17%	1.4M	16.22	View chart
908 Devices Common Stocks (MASS)	2.1	$22M	+135%	2.5M	8.76	View chart
Merus Nv Common Stocks (MRUS)	2.0	$21M	NEW	224k	94.15	View chart
Rhythm Pharmaceuticals Common Stocks (RYTM)	1.7	$18M	NEW	181k	100.99	View chart
Guardant Health Common Stocks (GH)	1.6	$18M	+117%	280k	62.48	View chart
Koru Medical Systems Common Stocks (KRMD)	1.6	$17M	-3%	4.5M	3.83	View chart
Establishment Labs Holdings Common Stocks (ESTA)	1.6	$17M		418k	40.99	View chart
Adma Biologics Common Stocks (ADMA)	1.5	$16M	+12%	1.1M	14.66	View chart
Disc Medicine Common Stocks (IRON)	1.4	$15M	NEW	231k	66.08	View chart
Vera Therapeutics Common Stocks (VERA)	1.4	$15M	-9%	507k	29.06	View chart
Neuropace Common Stocks (NPCE)	1.3	$14M		1.4M	10.31	View chart
Caris Life Sciences Common Stocks (CAI)	1.1	$12M	-8%	404k	29.42	View chart
Simulations Plus Common Stocks (SLP)	1.1	$12M	+114%	768k	15.07	View chart
Ultragenyx Pharmaceutical Common Stocks (RARE)	0.8	$8.6M	-47%	286k	30.08	View chart
Abivax Sa- Common Stocks (ABVX)	0.8	$8.1M	NEW	96k	84.90	View chart
Senseonics Holdings Common Stocks (SENS)	0.7	$7.8M	-49%	18M	0.44	View chart
Repligen Corp Common Stocks (RGEN)	0.5	$5.5M	-5%	41k	133.67	View chart
Structure Therapeutics Common Stocks (GPCR)	0.5	$5.5M	+61%	197k	28.00	View chart
Madrigal Pharmaceuticals Common Stocks (MDGL)	0.5	$5.3M	NEW	12k	458.66	View chart
Evolent Health Common Stocks (EVH)	0.4	$4.6M	-26%	545k	8.46	View chart
Alignment Healthcare Common Stocks (ALHC)	0.3	$3.5M	-47%	203k	17.45	View chart
Radnet Common Stocks (RDNT)	0.3	$3.2M	-38%	42k	76.21	View chart
Tectonic Therapeutics Common Stocks (TECX)	0.3	$3.2M	NEW	202k	15.69	View chart
Butterfly Network Common Stocks (BFLY)	0.2	$2.2M	-79%	1.1M	1.93	View chart

Past Filings by First Light Asset Management

SEC 13F filings are viewable for First Light Asset Management going back to 2013

First Light Asset Management 2025 Q3 filed Nov. 14, 2025
First Light Asset Management 2025 Q2 filed Aug. 14, 2025
First Light Asset Management 2025 Q1 filed May 15, 2025
First Light Asset Management 2024 Q4 filed Feb. 14, 2025
First Light Asset Management 2024 Q3 filed Nov. 14, 2024
First Light Asset Management 2024 Q2 filed Aug. 14, 2024
First Light Asset Management 2024 Q1 filed May 15, 2024
First Light Asset Management 2023 Q4 filed Feb. 14, 2024
First Light Asset Management 2023 Q3 filed Nov. 14, 2023
First Light Asset Management 2023 Q2 filed Aug. 14, 2023
First Light Asset Management 2023 Q1 filed May 15, 2023
First Light Asset Management 2022 Q4 filed Feb. 14, 2023
First Light Asset Management 2022 Q3 filed Nov. 14, 2022
First Light Asset Management 2022 Q2 filed Aug. 12, 2022
First Light Asset Management 2022 Q1 filed May 13, 2022
First Light Asset Management 2021 Q4 filed Feb. 14, 2022

View all past filings

Disclaimers: stockzoa.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on stockzoa.com represent a recommendation to purchase or sell a stock. The information on this site is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall stockzoa.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content available on stockzoa.com, or relating to the use of, or inability to use, stockzoa.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.

Fund Directory: 1-9 A B C D E F G H I J K L M N O P Q R S T U V W X-Z